{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:38:57Z","timestamp":1790649537146,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,6]],"date-time":"2016-11-06T00:00:00Z","timestamp":1478390400000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG037376"],"award-info":[{"award-number":["R01 AG037376"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG010124"],"award-info":[{"award-number":["P30 AG010124"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG040271"],"award-info":[{"award-number":["R01 AG040271"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["W81XWH-12-2\u20130012"],"award-info":[{"award-number":["W81XWH-12-2\u20130012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Araclon Biotech"},{"name":"BioClinica, Inc"},{"name":"Biogen Idec Inc"},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eisai Inc"},{"name":"Elan Pharmaceuticals, Inc"},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EuroImmun"},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005062","name":"Fujirebio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IXICO Ltd"},{"DOI":"10.13039\/100005205","name":"Janssen Alzheimer Immunotherapy Research & Development, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson & Johnson Pharmaceutical Research & Development LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medpace, Inc"},{"DOI":"10.13039\/100004334","name":"Merck & Co, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NeuroRx Research"},{"name":"Neurotrack Technologies"},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Piramal Imaging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Servier"},{"name":"Synarc Inc"},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.neurobiolaging.2015.08.029","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T17:31:18Z","timestamp":1441647078000},"page":"3152-3162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Suspected non-AD pathology in mild cognitive impairment"],"prefix":"10.1016","volume":"36","author":[{"given":"Laura E.M.","family":"Wisse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali","family":"Butala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhitsu R.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford C.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev N.","family":"Vaishnavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Yushkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans","volume":"6","author":"Aisen","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib2","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1021\/jm5017544","article-title":"Tau PET imaging: past, present and future","volume":"58","author":"Ariza","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archneur.63.2.246","article-title":"Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study","volume":"63","author":"Au","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.media.2007.06.004","article-title":"Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain","volume":"12","author":"Avants","year":"2008","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12021-011-9109-y","article-title":"An open source multivariate framework for n-tissue segmentation with evaluation on public data","volume":"9","author":"Avants","year":"2011","journal-title":"Neuroinformatics"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib6","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/HJH.0b013e32836184b5","article-title":"Blood pressure levels and brain volume reduction: a systematic review and meta-analysis","volume":"31","author":"Beauchet","year":"2013","journal-title":"J.\u00a0Hypertens"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/01688638708410764","article-title":"Episodic and semantic memory: a comparison of amnesic and demented patients","volume":"9","author":"Butters","year":"1987","journal-title":"J.\u00a0Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archneurol.2010.284","article-title":"Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative","volume":"67","author":"Carmichael","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.0000000000001209","article-title":"Mild cognitive impairment with suspected nonamyloid pathology (SNAP): prediction of progression","volume":"84","author":"Caroli","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.12.010","article-title":"Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors","volume":"20","author":"Chowdhury","year":"2011","journal-title":"J.Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuroimage.2008.12.016","article-title":"Registration based cortical thickness measurement","volume":"45","author":"Das","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib14","article-title":"Short-Term memory depends on dissociable medial temporal lobe regions in amnestic mild cognitive impairment","author":"Das","year":"2015","journal-title":"Cereb. Cortexa"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2015.08.029_bib15","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.neurobiolaging.2014.03.041","article-title":"Anterior and posterior MTL networks in aging and MCI","volume":"36","author":"Das","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib16","unstructured":"Davatzikos, C., Erus, G., Da, X., Doshi, J., Hierarchical Parcellation of MRI Using Multi-atlas Labeling Methods. Available at: http:\/\/adni.bitbucket.org\/upenn_roi_mars.html, 2014."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/01.WNL.0000149641.55751.2E","article-title":"Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe","volume":"64","author":"den Heijer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jalz.2012.01.006","article-title":"Amyloid positron emission tomography with (18)F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer's disease","volume":"9","author":"Duara","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/01688639108405109","article-title":"Development and validation of a model for estimating premorbid verbal intelligence in the elderly","volume":"13","author":"Grober","year":"1991","journal-title":"J.\u00a0Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11682-012-9180-5","article-title":"Cortical signatures of cognition and their relationship to Alzheimer's disease","volume":"6","author":"Gross","year":"2012","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00401-014-1362-3","article-title":"PART and SNAP","volume":"128","author":"Jack","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib25","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/01.wnl.0000435556.21319.e4","article-title":"Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity","volume":"81","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib26","series-title":"The Boston Naming Test","author":"Kaplan","year":"1983"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib27","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1212\/WNL.0b013e3182563bbe","article-title":"Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease","volume":"78","author":"Knopman","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on beta-amyloid in normal elderly","volume":"73","author":"Knopman","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","article-title":"Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals","volume":"71","author":"Mormino","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib31","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0010-9452(78)80049-5","article-title":"Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test","volume":"14","author":"Nelson","year":"1978","journal-title":"Cortex"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hbm.1058","article-title":"Nonparametric permutation tests for functional neuroimaging: a primer with examples","volume":"15","author":"Nichols","year":"2002","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ana.23931","article-title":"Mild cognitive impairment due to Alzheimer disease in the community","volume":"74","author":"Petersen","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archneur.63.5.665","article-title":"Neuropathologic features of amnestic mild cognitive impairment","volume":"63","author":"Petersen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0b013e3182872830","article-title":"Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease","volume":"80","author":"Prestia","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib37","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awh553","article-title":"Cerebral small-vessel disease and decline in information processing speed, executive function and memory","volume":"128","author":"Prins","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib38","doi-asserted-by":"crossref","unstructured":"Reitan, R.M., 1958. Validity of the trail making test as an indicator of organic brain damage. 8, 271\u2013276.","DOI":"10.2466\/pms.1958.8.3.271"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib39","series-title":"L'examen clinique en psychologie","author":"Rey","year":"1964"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib40","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A\u00a0new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jalz.2010.03.013","article-title":"Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans","volume":"6","author":"Saykin","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib42","first-page":"239","article-title":"Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR","volume":"21","author":"Schwarz","year":"2009","journal-title":"Inf. Process. Med. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib44","series-title":"Clinical Gerontology: A Guide to Assessment and Intervention","first-page":"165","article-title":"Geriatric Depression Scale (GDS): recent evidence and development of a shorter versioin","author":"Sheikh","year":"1986"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2015.08.029_bib45","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroimage.2008.03.061","article-title":"Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference","volume":"44","author":"Smith","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/STROKEAHA.114.007146","article-title":"Relationship between white matter hyperintensities, cortical thickness, and cognition","volume":"46","author":"Tuladhar","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroimage.2014.05.044","article-title":"Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements","volume":"99","author":"Tustison","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuroimage.2010.12.073","article-title":"Antemortem differential diagnosis of dementia pathology using structural MRI: differential-STAND","volume":"55","author":"Vemuri","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib51","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.08.029_bib52","first-page":"1512","article-title":"Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people","volume":"70","author":"Wirth","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015004479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015004479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:56:40Z","timestamp":1712379400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015004479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0197458015004479"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.029","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suspected non-AD pathology in mild cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}